"datasourceId","Drug_brand_name","TA","noTarget","interactionAssociation","phenotypeAssociation","score","datasourceName","datasourceType","Year"
"cancer_biomarkers","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Voclosporin","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Viloxazine","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Ublituximab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tezepelumab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Terlipressin","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tebentafusp","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Sutimlimab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","SRP-9001","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","SER-109","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","RSVpreF","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Ponesimod","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Pafolacianine","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Oteseconazole","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Olorofim","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Nedosiran","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Maribavir","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Lenacapavir","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","GSK3844766A","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Fosdenopterin","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Fexinidazole","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Evinacumab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Difelikefalin","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Casimersen","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Belumosudil","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Avacopan","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Atogepant","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Anifrolumab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Anacaulase","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Aducanumab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Zuranolone","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Zuranolone","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Tremelimumab","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Umbralisib","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Odevixibat","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Maralixibat","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Finerenone","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Eflapegrastim","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Teclistamab","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Talquetamab","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Dasiglucagon","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Belzutifan","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Vosoritide","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Deucravacitinib","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tapinarof","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Concizumab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Concizumab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Faricimab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Teplizumab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Inclisiran","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Dostarlimab","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,TRUE,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Daridorexant","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Daridorexant","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Mitapivat","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Trilaciclib","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Futibatinib","Oncology",FALSE,TRUE,TRUE,0.607930797611621,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tralokinumab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Abrocitinib","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Abrocitinib","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Momelotinib","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Vericiguat","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Pacritinib","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Ganaxolone","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Repotrectinib","Oncology",FALSE,TRUE,TRUE,0.936072224944711,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Tirzepatide","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tivozanib","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Infigratinib","Oncology",FALSE,TRUE,TRUE,0.607930797611621,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Tepotinib","Oncology",FALSE,TRUE,TRUE,0.919067987742997,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Asciminib","Oncology",FALSE,TRUE,TRUE,0.967152948166419,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Olutasidenib","Oncology",FALSE,TRUE,TRUE,0.827461363415818,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Spesolimab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Lecanemab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Donanemab","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Vutrisiran","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Sotorasib","Oncology",FALSE,TRUE,TRUE,0.942151532920827,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Adagrasib","Oncology",FALSE,TRUE,TRUE,0.942151532920827,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tofersen","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Valoctocogene roxaparvovec","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Olipudase alfa","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Mavacamten","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Mobocertinib","Oncology",FALSE,TRUE,TRUE,0.968836966996368,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Amivantamab","Oncology",FALSE,TRUE,TRUE,0.968836966996368,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_gene_census","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Voclosporin","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Viloxazine","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Ublituximab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tezepelumab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Terlipressin","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tebentafusp","Oncology",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Sutimlimab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","SRP-9001","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","SER-109","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","RSVpreF","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Ponesimod","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Pafolacianine","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Oteseconazole","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Olorofim","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Nedosiran","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Maribavir","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Lenacapavir","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","GSK3844766A","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Gadopiclenol","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Fosdenopterin","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Fexinidazole","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Evinacumab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Difelikefalin","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Casimersen","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Belumosudil","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Avacopan","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Atogepant","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Anifrolumab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Anacaulase","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Aducanumab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Zuranolone","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Zuranolone","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Tremelimumab","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Umbralisib","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Odevixibat","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Maralixibat","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Finerenone","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Eflapegrastim","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tisotumab vedotin","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Mirvetuximab soravtansine","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Teclistamab","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Talquetamab","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Dasiglucagon","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Belzutifan","Oncology",FALSE,NA,TRUE,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Vosoritide","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Deucravacitinib","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tapinarof","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Concizumab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Concizumab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Faricimab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Teplizumab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Inclisiran","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Dostarlimab","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Daridorexant","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Daridorexant","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Mitapivat","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Trilaciclib","Oncology",FALSE,TRUE,TRUE,0.455948098208716,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Futibatinib","Oncology",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tralokinumab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Abrocitinib","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Abrocitinib","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Momelotinib","Oncology",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Vericiguat","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Pacritinib","Oncology",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Ganaxolone","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Repotrectinib","Oncology",FALSE,TRUE,TRUE,0.851229768905772,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Tirzepatide","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tivozanib","Oncology",FALSE,TRUE,TRUE,0.622706893386904,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Infigratinib","Oncology",FALSE,TRUE,TRUE,0.7219178221638,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Tepotinib","Oncology",FALSE,TRUE,TRUE,0.88402882441722,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Asciminib","Oncology",FALSE,TRUE,TRUE,0.759913497014526,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Olutasidenib","Oncology",FALSE,TRUE,TRUE,0.531939447910168,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Spesolimab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Lecanemab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Donanemab","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Vutrisiran","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Sotorasib","Oncology",FALSE,TRUE,TRUE,0.842931461823577,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Adagrasib","Oncology",FALSE,TRUE,TRUE,0.842931461823577,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tofersen","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Valoctocogene roxaparvovec","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Olipudase alfa","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Mavacamten","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Mobocertinib","Oncology",FALSE,TRUE,TRUE,0.926746075358155,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Amivantamab","Oncology",FALSE,TRUE,TRUE,0.926746075358155,"CGC (COSMIC)","Somatic",2021
"clingen","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Voclosporin","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Viloxazine","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Ublituximab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tezepelumab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Terlipressin","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tebentafusp","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Sutimlimab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","SRP-9001","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","SER-109","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","RSVpreF","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Ponesimod","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Pafolacianine","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Oteseconazole","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Olorofim","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Nedosiran","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Maribavir","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Lenacapavir","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","GSK3844766A","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Fosdenopterin","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Fexinidazole","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Evinacumab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Difelikefalin","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Casimersen","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Belumosudil","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Avacopan","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Atogepant","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Anifrolumab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Anacaulase","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Aducanumab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Zuranolone","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Zuranolone","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Tremelimumab","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Umbralisib","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Odevixibat","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Maralixibat","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Finerenone","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Eflapegrastim","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Teclistamab","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Talquetamab","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Dasiglucagon","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Belzutifan","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Vosoritide","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Deucravacitinib","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tapinarof","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Concizumab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Concizumab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Faricimab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Teplizumab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Inclisiran","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Dostarlimab","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Daridorexant","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Daridorexant","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Mitapivat","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Trilaciclib","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Futibatinib","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tralokinumab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Abrocitinib","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Abrocitinib","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Momelotinib","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Vericiguat","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Pacritinib","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Ganaxolone","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Repotrectinib","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Tirzepatide","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tivozanib","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Infigratinib","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Tepotinib","Oncology",FALSE,TRUE,NA,0,"Clingen","Rare mendelian",2021
"clingen","Asciminib","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Olutasidenib","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Spesolimab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Lecanemab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Donanemab","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Vutrisiran","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Sotorasib","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Adagrasib","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tofersen","Other indication",FALSE,TRUE,TRUE,0.827461363415818,"Clingen","Rare mendelian",2023
"clingen","Valoctocogene roxaparvovec","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Clingen","Rare mendelian",2023
"clingen","Olipudase alfa","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Clingen","Rare mendelian",2022
"clingen","Mavacamten","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Clingen","Rare mendelian",2022
"clingen","Mobocertinib","Oncology",FALSE,TRUE,TRUE,0.607930797611621,"Clingen","Rare mendelian",2021
"clingen","Amivantamab","Oncology",FALSE,TRUE,TRUE,0.607930797611621,"Clingen","Rare mendelian",2021
"crispr","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Voclosporin","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Viloxazine","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Ublituximab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Tezepelumab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Terlipressin","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Tebentafusp","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Sutimlimab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","SRP-9001","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","SER-109","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","RSVpreF","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Ponesimod","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Pafolacianine","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Oteseconazole","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Olorofim","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Nedosiran","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Maribavir","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Lenacapavir","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","GSK3844766A","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Fosdenopterin","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Fexinidazole","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Evinacumab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Difelikefalin","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Casimersen","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Belumosudil","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Avacopan","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Atogepant","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Anifrolumab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Anacaulase","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Aducanumab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Zuranolone","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Zuranolone","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Tremelimumab","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Umbralisib","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Odevixibat","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Maralixibat","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Finerenone","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Eflapegrastim","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Mirvetuximab soravtansine","Oncology",FALSE,TRUE,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Teclistamab","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Talquetamab","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Dasiglucagon","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Belzutifan","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Vosoritide","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Deucravacitinib","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Tapinarof","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Concizumab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Concizumab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Faricimab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Teplizumab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Inclisiran","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Dostarlimab","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Daridorexant","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Daridorexant","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Mitapivat","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Trilaciclib","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Futibatinib","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Tralokinumab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Abrocitinib","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Abrocitinib","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Momelotinib","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Vericiguat","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Pacritinib","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Ganaxolone","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Repotrectinib","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Tirzepatide","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Tivozanib","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Infigratinib","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Tepotinib","Oncology",FALSE,TRUE,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Asciminib","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Olutasidenib","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Spesolimab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Lecanemab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Donanemab","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Vutrisiran","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Sotorasib","Oncology",FALSE,TRUE,TRUE,0.272428988679708,"Project Score","Functional genomics (cancer)",2021
"crispr","Adagrasib","Oncology",FALSE,TRUE,TRUE,0.272428988679708,"Project Score","Functional genomics (cancer)",2022
"crispr","Tofersen","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Valoctocogene roxaparvovec","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Olipudase alfa","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Mavacamten","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Mobocertinib","Oncology",FALSE,TRUE,TRUE,0.378816878261741,"Project Score","Functional genomics (cancer)",2021
"crispr","Amivantamab","Oncology",FALSE,TRUE,TRUE,0.378816878261741,"Project Score","Functional genomics (cancer)",2021
"eva","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Voclosporin","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Viloxazine","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Ublituximab","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Tezepelumab","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Terlipressin","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Tebentafusp","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Sutimlimab","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","SRP-9001","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","SER-109","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","RSVpreF","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Ponesimod","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Pafolacianine","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Oteseconazole","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Olorofim","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Nedosiran","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2023
"eva","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Maribavir","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Lenacapavir","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","GSK3844766A","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Gadopiclenol","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Fosdenopterin","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Fexinidazole","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Evinacumab","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Difelikefalin","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Casimersen","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Belumosudil","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Avacopan","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Atogepant","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Anifrolumab","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Anacaulase","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Aducanumab","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Zuranolone","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2023
"eva","Zuranolone","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2023
"eva","Tremelimumab","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Umbralisib","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Odevixibat","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Maralixibat","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Finerenone","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Eflapegrastim","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Teclistamab","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Talquetamab","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2023
"eva","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Dasiglucagon","Other indication",FALSE,NA,TRUE,0,"ClinVar","Rare mendelian",2021
"eva","Belzutifan","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Vosoritide","Other indication",FALSE,NA,TRUE,0,"ClinVar","Rare mendelian",2021
"eva","Deucravacitinib","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Tapinarof","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Concizumab","Other indication",FALSE,NA,TRUE,0,"ClinVar","Rare mendelian",2023
"eva","Concizumab","Other indication",FALSE,NA,TRUE,0,"ClinVar","Rare mendelian",2023
"eva","Faricimab","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Teplizumab","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Inclisiran","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Dostarlimab","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,TRUE,NA,0,"ClinVar","Rare mendelian",2022
"eva","Daridorexant","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Daridorexant","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Mitapivat","Other indication",FALSE,TRUE,TRUE,0.425551558328135,"ClinVar","Rare mendelian",2022
"eva","Trilaciclib","Oncology",FALSE,TRUE,NA,0,"ClinVar","Rare mendelian",2021
"eva","Futibatinib","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Tralokinumab","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Abrocitinib","Other indication",FALSE,TRUE,NA,0,"ClinVar","Rare mendelian",2022
"eva","Abrocitinib","Other indication",FALSE,TRUE,NA,0,"ClinVar","Rare mendelian",2022
"eva","Momelotinib","Oncology",FALSE,TRUE,TRUE,0.665684223384725,"ClinVar","Rare mendelian",2023
"eva","Vericiguat","Other indication",FALSE,NA,TRUE,0,"ClinVar","Rare mendelian",2021
"eva","Pacritinib","Oncology",FALSE,TRUE,TRUE,0.665684223384725,"ClinVar","Rare mendelian",2022
"eva","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Lonapegsomatropin","Other indication",FALSE,TRUE,TRUE,0.559296333802691,"ClinVar","Rare mendelian",2021
"eva","Ganaxolone","Other indication",FALSE,TRUE,TRUE,0.594421224331363,"ClinVar","Rare mendelian",2022
"eva","Repotrectinib","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2023
"eva","Tirzepatide","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Tivozanib","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Avalglucosidase alfa","Other indication",FALSE,TRUE,TRUE,0.968618748594972,"ClinVar","Rare mendelian",2021
"eva","Infigratinib","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Tepotinib","Oncology",FALSE,TRUE,NA,0,"ClinVar","Rare mendelian",2021
"eva","Asciminib","Oncology",FALSE,TRUE,TRUE,0.732556611122003,"ClinVar","Rare mendelian",2021
"eva","Olutasidenib","Oncology",FALSE,TRUE,TRUE,0.559296333802691,"ClinVar","Rare mendelian",2022
"eva","Spesolimab","Other indication",FALSE,TRUE,TRUE,0.825852610441943,"ClinVar","Rare mendelian",2022
"eva","Lecanemab","Other indication",FALSE,TRUE,TRUE,0.874357153360333,"ClinVar","Rare mendelian",2023
"eva","Donanemab","Other indication",FALSE,TRUE,TRUE,0.874357153360333,"ClinVar","Rare mendelian",2023
"eva","Vutrisiran","Other indication",FALSE,TRUE,TRUE,0.946899854872392,"ClinVar","Rare mendelian",2022
"eva","Sotorasib","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Adagrasib","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Tofersen","Other indication",FALSE,TRUE,TRUE,0.946614845449127,"ClinVar","Rare mendelian",2023
"eva","Valoctocogene roxaparvovec","Other indication",FALSE,TRUE,TRUE,0.947477974709936,"ClinVar","Rare mendelian",2023
"eva","Olipudase alfa","Other indication",FALSE,TRUE,TRUE,0.948440804220414,"ClinVar","Rare mendelian",2022
"eva","Mavacamten","Other indication",FALSE,TRUE,TRUE,0.967940751982116,"ClinVar","Rare mendelian",2022
"eva","Mobocertinib","Oncology",FALSE,TRUE,TRUE,0.823172073899336,"ClinVar","Rare mendelian",2021
"eva","Amivantamab","Oncology",FALSE,TRUE,TRUE,0.823172073899336,"ClinVar","Rare mendelian",2021
"eva_somatic","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Voclosporin","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Viloxazine","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Ublituximab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tezepelumab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Terlipressin","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tebentafusp","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Sutimlimab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","SRP-9001","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","SER-109","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","RSVpreF","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Ponesimod","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Pafolacianine","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Oteseconazole","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Olorofim","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Nedosiran","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Maribavir","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Lenacapavir","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","GSK3844766A","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Gadopiclenol","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Fosdenopterin","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Fexinidazole","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Evinacumab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Difelikefalin","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Casimersen","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Belumosudil","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Avacopan","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Atogepant","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Anifrolumab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Anacaulase","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Aducanumab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Zuranolone","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Zuranolone","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Tremelimumab","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Umbralisib","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Ropeginterferon alfa-2b","Oncology",FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Odevixibat","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Maralixibat","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Finerenone","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Eflapegrastim","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tisotumab vedotin","Oncology",FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Teclistamab","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Talquetamab","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Dasiglucagon","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Belzutifan","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Vosoritide","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Deucravacitinib","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tapinarof","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Concizumab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Concizumab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Faricimab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Teplizumab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Inclisiran","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Dostarlimab","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Daridorexant","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Daridorexant","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Mitapivat","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Trilaciclib","Oncology",FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Futibatinib","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tralokinumab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Abrocitinib","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Abrocitinib","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Momelotinib","Oncology",FALSE,TRUE,TRUE,0.547137717850459,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Vericiguat","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Pacritinib","Oncology",FALSE,TRUE,TRUE,0.547137717850459,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Ganaxolone","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Repotrectinib","Oncology",FALSE,TRUE,TRUE,0.547137717850459,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Tirzepatide","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tivozanib","Oncology",FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Infigratinib","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Tepotinib","Oncology",FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Asciminib","Oncology",FALSE,TRUE,TRUE,0.808573424292028,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Olutasidenib","Oncology",FALSE,TRUE,TRUE,0.832123889357364,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Spesolimab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Lecanemab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Donanemab","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Vutrisiran","Other indication",FALSE,TRUE,TRUE,0.699120417253364,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Sotorasib","Oncology",FALSE,TRUE,TRUE,0.893596278167008,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Adagrasib","Oncology",FALSE,TRUE,TRUE,0.893596278167008,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tofersen","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Valoctocogene roxaparvovec","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Olipudase alfa","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Mavacamten","Other indication",FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Mobocertinib","Oncology",FALSE,TRUE,TRUE,0.900195720739544,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Amivantamab","Oncology",FALSE,TRUE,TRUE,0.900195720739544,"ClinVar (Somatic)","Somatic",2021
"gene2phenotype","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Voclosporin","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Viloxazine","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Ublituximab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tezepelumab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Terlipressin","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tebentafusp","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Sutimlimab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","SRP-9001","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","SER-109","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","RSVpreF","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Ponesimod","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Pafolacianine","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Oteseconazole","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Olorofim","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Nedosiran","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Maribavir","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Lenacapavir","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","GSK3844766A","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Gadopiclenol","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Fosdenopterin","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Fexinidazole","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Evinacumab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Difelikefalin","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Casimersen","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Belumosudil","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Avacopan","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Atogepant","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Anifrolumab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Anacaulase","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Aducanumab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Zuranolone","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Zuranolone","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Tremelimumab","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Umbralisib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Odevixibat","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Maralixibat","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Finerenone","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Eflapegrastim","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Teclistamab","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Talquetamab","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Dasiglucagon","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Belzutifan","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Vosoritide","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Deucravacitinib","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tapinarof","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Concizumab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Concizumab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Faricimab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Teplizumab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Inclisiran","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Dostarlimab","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Daridorexant","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Daridorexant","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Mitapivat","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Trilaciclib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Futibatinib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tralokinumab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Abrocitinib","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Abrocitinib","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Momelotinib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Vericiguat","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Pacritinib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Ganaxolone","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Repotrectinib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Tirzepatide","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tivozanib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Infigratinib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Tepotinib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Asciminib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Olutasidenib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Spesolimab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Lecanemab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Donanemab","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Vutrisiran","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Sotorasib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Adagrasib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tofersen","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Valoctocogene roxaparvovec","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Olipudase alfa","Other indication",FALSE,TRUE,TRUE,0.759913497014526,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Mavacamten","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Mobocertinib","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Amivantamab","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene_burden","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Voclosporin","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Viloxazine","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Ublituximab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tezepelumab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Terlipressin","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tebentafusp","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Sutimlimab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","SRP-9001","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","SER-109","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","RSVpreF","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Ponesimod","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Pafolacianine","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Oteseconazole","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Olorofim","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Nedosiran","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Maribavir","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Lenacapavir","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","GSK3844766A","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Fosdenopterin","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Fexinidazole","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Evinacumab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Difelikefalin","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Casimersen","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Belumosudil","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Avacopan","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Atogepant","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Anifrolumab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Anacaulase","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Aducanumab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Zuranolone","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Zuranolone","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Tremelimumab","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Umbralisib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Odevixibat","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Maralixibat","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Finerenone","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Eflapegrastim","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Teclistamab","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Talquetamab","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Dasiglucagon","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Belzutifan","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Vosoritide","Other indication",FALSE,NA,TRUE,0,"Gene burden","Common disease",2021
"gene_burden","Deucravacitinib","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tapinarof","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Concizumab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Concizumab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Faricimab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Teplizumab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Inclisiran","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Dostarlimab","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Daridorexant","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Daridorexant","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Mitapivat","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Trilaciclib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Futibatinib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tralokinumab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Abrocitinib","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Abrocitinib","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Momelotinib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Vericiguat","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Pacritinib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Ganaxolone","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Repotrectinib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Tirzepatide","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tivozanib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Infigratinib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Tepotinib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Asciminib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Olutasidenib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Spesolimab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Lecanemab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Donanemab","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Vutrisiran","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Sotorasib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Adagrasib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tofersen","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Valoctocogene roxaparvovec","Other indication",FALSE,TRUE,TRUE,0.933424244697778,"Gene burden","Common disease",2023
"gene_burden","Olipudase alfa","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Mavacamten","Other indication",FALSE,TRUE,TRUE,0.69370813621813,"Gene burden","Common disease",2022
"gene_burden","Mobocertinib","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Amivantamab","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"genomics_england","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Voclosporin","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Viloxazine","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Ublituximab","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tezepelumab","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Terlipressin","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tebentafusp","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Sutimlimab","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","SRP-9001","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","SER-109","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","RSVpreF","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Ponesimod","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Pafolacianine","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Oteseconazole","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Olorofim","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Nedosiran","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Maribavir","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Lenacapavir","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","GSK3844766A","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Gadopiclenol","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Fosdenopterin","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Fexinidazole","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Evinacumab","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Difelikefalin","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Casimersen","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Belumosudil","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Avacopan","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Atogepant","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Anifrolumab","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Anacaulase","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Aducanumab","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Zuranolone","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Zuranolone","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Tremelimumab","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Umbralisib","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Odevixibat","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Maralixibat","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Finerenone","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Eflapegrastim","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Teclistamab","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Talquetamab","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Dasiglucagon","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Belzutifan","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Vosoritide","Other indication",FALSE,NA,TRUE,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Deucravacitinib","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tapinarof","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Concizumab","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Concizumab","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Faricimab","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Teplizumab","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Inclisiran","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Dostarlimab","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Daridorexant","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Daridorexant","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Mitapivat","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Trilaciclib","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Futibatinib","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tralokinumab","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Abrocitinib","Other indication",FALSE,TRUE,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Abrocitinib","Other indication",FALSE,TRUE,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Momelotinib","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Vericiguat","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Pacritinib","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Lonapegsomatropin","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Ganaxolone","Other indication",FALSE,TRUE,TRUE,0.759913497014526,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Repotrectinib","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Tirzepatide","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tivozanib","Oncology",FALSE,TRUE,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Infigratinib","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Tepotinib","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Asciminib","Oncology",FALSE,TRUE,TRUE,0.607930797611621,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Olutasidenib","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Spesolimab","Other indication",FALSE,TRUE,TRUE,0.906661236771331,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Lecanemab","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Donanemab","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Vutrisiran","Other indication",FALSE,TRUE,TRUE,0.939111878932769,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Sotorasib","Oncology",FALSE,TRUE,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Adagrasib","Oncology",FALSE,TRUE,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tofersen","Other indication",FALSE,TRUE,TRUE,0.759913497014526,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Valoctocogene roxaparvovec","Other indication",FALSE,TRUE,TRUE,0.759913497014526,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Olipudase alfa","Other indication",FALSE,TRUE,TRUE,0.971735321876137,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Mavacamten","Other indication",FALSE,TRUE,TRUE,0.947175754388692,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Mobocertinib","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Amivantamab","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"impc","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2022
"impc","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2022
"impc","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2022
"impc","Voclosporin","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Viloxazine","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Ublituximab","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Tezepelumab","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Terlipressin","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Tebentafusp","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Sutimlimab","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","SRP-9001","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2023
"impc","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2022
"impc","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2022
"impc","SER-109","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2023
"impc","RSVpreF","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2023
"impc","Ponesimod","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2021
"impc","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Pafolacianine","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2021
"impc","Oteseconazole","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2022
"impc","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Olorofim","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2023
"impc","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Nedosiran","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2023
"impc","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2021
"impc","Maribavir","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2021
"impc","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Lenacapavir","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2022
"impc","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2021
"impc","GSK3844766A","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2023
"impc","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2022
"impc","Fosdenopterin","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2021
"impc","Fexinidazole","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2021
"impc","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2023
"impc","Evinacumab","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2023
"impc","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Difelikefalin","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Casimersen","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2021
"impc","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2023
"impc","Belumosudil","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Avacopan","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Atogepant","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Anifrolumab","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Anacaulase","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)","Mouse model",2022
"impc","Aducanumab","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Zuranolone","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2023
"impc","Zuranolone","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2023
"impc","Tremelimumab","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Umbralisib","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Ropeginterferon alfa-2b","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Odevixibat","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Mosunetuzumab","Oncology",FALSE,NA,TRUE,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Maralixibat","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Finerenone","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Eflapegrastim","Other indication",FALSE,NA,TRUE,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Teclistamab","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Talquetamab","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)","Mouse model",2023
"impc","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Dasiglucagon","Other indication",FALSE,NA,TRUE,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Belzutifan","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Vosoritide","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Deucravacitinib","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Tapinarof","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Concizumab","Other indication",FALSE,TRUE,TRUE,0.340927591300597,"Mouse model (IMPC)","Mouse model",2023
"impc","Concizumab","Other indication",FALSE,TRUE,TRUE,0.340927591300597,"Mouse model (IMPC)","Mouse model",2023
"impc","Faricimab","Other indication",FALSE,TRUE,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Teplizumab","Other indication",FALSE,TRUE,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Inclisiran","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Dostarlimab","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Daridorexant","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Daridorexant","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Mitapivat","Other indication",FALSE,TRUE,TRUE,0.261653415292042,"Mouse model (IMPC)","Mouse model",2022
"impc","Trilaciclib","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Futibatinib","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Tralokinumab","Other indication",FALSE,TRUE,TRUE,0.347440894318342,"Mouse model (IMPC)","Mouse model",2021
"impc","Abrocitinib","Other indication",FALSE,TRUE,TRUE,0.412009899811336,"Mouse model (IMPC)","Mouse model",2022
"impc","Abrocitinib","Other indication",FALSE,TRUE,TRUE,0.412009899811336,"Mouse model (IMPC)","Mouse model",2022
"impc","Momelotinib","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2023
"impc","Vericiguat","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Pacritinib","Oncology",FALSE,TRUE,TRUE,0.269070171022903,"Mouse model (IMPC)","Mouse model",2022
"impc","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,TRUE,TRUE,0.818087408255978,"Mouse model (IMPC)","Mouse model",2021
"impc","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,TRUE,TRUE,0.818087408255978,"Mouse model (IMPC)","Mouse model",2021
"impc","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Ganaxolone","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Repotrectinib","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)","Mouse model",2023
"impc","Tirzepatide","Other indication",FALSE,TRUE,TRUE,0.787954305054362,"Mouse model (IMPC)","Mouse model",2022
"impc","Tivozanib","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Avalglucosidase alfa","Other indication",FALSE,TRUE,TRUE,0.484040698575115,"Mouse model (IMPC)","Mouse model",2021
"impc","Infigratinib","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Tepotinib","Oncology",FALSE,TRUE,TRUE,0.346642140798146,"Mouse model (IMPC)","Mouse model",2021
"impc","Asciminib","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Olutasidenib","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Spesolimab","Other indication",FALSE,TRUE,TRUE,0.432162805752161,"Mouse model (IMPC)","Mouse model",2022
"impc","Lecanemab","Other indication",FALSE,TRUE,TRUE,0.439468951851791,"Mouse model (IMPC)","Mouse model",2023
"impc","Donanemab","Other indication",FALSE,TRUE,TRUE,0.439468951851791,"Mouse model (IMPC)","Mouse model",2023
"impc","Vutrisiran","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)","Mouse model",2022
"impc","Sotorasib","Oncology",FALSE,TRUE,TRUE,0.415551096707424,"Mouse model (IMPC)","Mouse model",2021
"impc","Adagrasib","Oncology",FALSE,TRUE,TRUE,0.415551096707424,"Mouse model (IMPC)","Mouse model",2022
"impc","Tofersen","Other indication",FALSE,TRUE,TRUE,0.438443676561619,"Mouse model (IMPC)","Mouse model",2023
"impc","Valoctocogene roxaparvovec","Other indication",FALSE,TRUE,NA,0,"Mouse model (IMPC)","Mouse model",2023
"impc","Olipudase alfa","Other indication",FALSE,TRUE,TRUE,0.260802312175385,"Mouse model (IMPC)","Mouse model",2022
"impc","Mavacamten","Other indication",FALSE,TRUE,TRUE,0.414794138429564,"Mouse model (IMPC)","Mouse model",2022
"impc","Mobocertinib","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)","Mouse model",2021
"impc","Amivantamab","Oncology",FALSE,TRUE,TRUE,0.346642140798146,"Mouse model (IMPC)","Mouse model",2021
"intogen","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Voclosporin","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Viloxazine","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Ublituximab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Tezepelumab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Terlipressin","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Tebentafusp","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Sutimlimab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","SRP-9001","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","SER-109","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","RSVpreF","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Ponesimod","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Pafolacianine","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Oteseconazole","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Olorofim","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Nedosiran","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Maribavir","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Lenacapavir","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","GSK3844766A","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Gadopiclenol","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Fosdenopterin","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Fexinidazole","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Evinacumab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Difelikefalin","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Casimersen","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Belumosudil","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Avacopan","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Atogepant","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Anifrolumab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Anacaulase","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Aducanumab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Zuranolone","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Zuranolone","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Tremelimumab","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Umbralisib","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Odevixibat","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Maralixibat","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Finerenone","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Eflapegrastim","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Tisotumab vedotin","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2021
"intogen","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Teclistamab","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Talquetamab","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2022
"intogen","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2022
"intogen","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2022
"intogen","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2022
"intogen","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2022
"intogen","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2022
"intogen","Dasiglucagon","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Belzutifan","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Vosoritide","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Deucravacitinib","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Tapinarof","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Concizumab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Concizumab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Faricimab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Teplizumab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Inclisiran","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Dostarlimab","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2022
"intogen","Daridorexant","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Daridorexant","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Mitapivat","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Trilaciclib","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2021
"intogen","Futibatinib","Oncology",FALSE,TRUE,TRUE,0.322779459545566,"IntOgen","Somatic",2022
"intogen","Tralokinumab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Abrocitinib","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Abrocitinib","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Momelotinib","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Vericiguat","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Pacritinib","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Ganaxolone","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Repotrectinib","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Tirzepatide","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Tivozanib","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2021
"intogen","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Infigratinib","Oncology",FALSE,TRUE,TRUE,0.322779459545566,"IntOgen","Somatic",2021
"intogen","Tepotinib","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2021
"intogen","Asciminib","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Olutasidenib","Oncology",FALSE,TRUE,TRUE,0.801779693110174,"IntOgen","Somatic",2022
"intogen","Spesolimab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Lecanemab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Donanemab","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Vutrisiran","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Sotorasib","Oncology",FALSE,TRUE,TRUE,0.865457038266544,"IntOgen","Somatic",2021
"intogen","Adagrasib","Oncology",FALSE,TRUE,TRUE,0.865457038266544,"IntOgen","Somatic",2022
"intogen","Tofersen","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Valoctocogene roxaparvovec","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Olipudase alfa","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Mavacamten","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Mobocertinib","Oncology",FALSE,TRUE,TRUE,0.850675779255117,"IntOgen","Somatic",2021
"intogen","Amivantamab","Oncology",FALSE,TRUE,TRUE,0.850675779255117,"IntOgen","Somatic",2021
"orphanet","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Voclosporin","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Viloxazine","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Ublituximab","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tezepelumab","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Terlipressin","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tebentafusp","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Sutimlimab","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","SRP-9001","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","SER-109","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","RSVpreF","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Ponesimod","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Pafolacianine","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Oteseconazole","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Olorofim","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Nedosiran","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2023
"orphanet","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Maribavir","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Lenacapavir","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","GSK3844766A","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Fosdenopterin","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Fexinidazole","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Evinacumab","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Difelikefalin","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Casimersen","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Belumosudil","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Avacopan","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Atogepant","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Anifrolumab","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Anacaulase","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Aducanumab","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Zuranolone","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2023
"orphanet","Zuranolone","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2023
"orphanet","Tremelimumab","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Umbralisib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Odevixibat","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Maralixibat","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Finerenone","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Eflapegrastim","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Teclistamab","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Talquetamab","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2023
"orphanet","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Dasiglucagon","Other indication",FALSE,NA,TRUE,0,"Orphanet","Rare mendelian",2021
"orphanet","Belzutifan","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Vosoritide","Other indication",FALSE,NA,TRUE,0,"Orphanet","Rare mendelian",2021
"orphanet","Deucravacitinib","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tapinarof","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Concizumab","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2023
"orphanet","Concizumab","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2023
"orphanet","Faricimab","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Teplizumab","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Inclisiran","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Dostarlimab","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Daridorexant","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Daridorexant","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Mitapivat","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Trilaciclib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Futibatinib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tralokinumab","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Abrocitinib","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Abrocitinib","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Momelotinib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2023
"orphanet","Vericiguat","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Pacritinib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Ganaxolone","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Repotrectinib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2023
"orphanet","Tirzepatide","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tivozanib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Infigratinib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Tepotinib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Asciminib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Olutasidenib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Spesolimab","Other indication",FALSE,TRUE,TRUE,0.827461363415818,"Orphanet","Rare mendelian",2022
"orphanet","Lecanemab","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Orphanet","Rare mendelian",2023
"orphanet","Donanemab","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Orphanet","Rare mendelian",2023
"orphanet","Vutrisiran","Other indication",FALSE,TRUE,TRUE,0.759913497014526,"Orphanet","Rare mendelian",2022
"orphanet","Sotorasib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Adagrasib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tofersen","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Orphanet","Rare mendelian",2023
"orphanet","Valoctocogene roxaparvovec","Other indication",FALSE,TRUE,TRUE,0.865457038266544,"Orphanet","Rare mendelian",2023
"orphanet","Olipudase alfa","Other indication",FALSE,TRUE,TRUE,0.759913497014526,"Orphanet","Rare mendelian",2022
"orphanet","Mavacamten","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Orphanet","Rare mendelian",2022
"orphanet","Mobocertinib","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Amivantamab","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"ot_genetics_portal","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Voclosporin","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Viloxazine","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Ublituximab","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tezepelumab","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Terlipressin","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tebentafusp","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Sutimlimab","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","SRP-9001","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","SER-109","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","RSVpreF","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Ponesimod","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Pafolacianine","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Oteseconazole","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Olorofim","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Nedosiran","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Maribavir","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Lenacapavir","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","GSK3844766A","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Gadopiclenol","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Fosdenopterin","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Fexinidazole","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Evinacumab","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Difelikefalin","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Casimersen","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Belumosudil","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Avacopan","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Atogepant","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Anifrolumab","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Anacaulase","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Aducanumab","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Zuranolone","Other indication",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Zuranolone","Other indication",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Tremelimumab","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Umbralisib","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Odevixibat","Other indication",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Maralixibat","Other indication",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Finerenone","Other indication",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Eflapegrastim","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Mirvetuximab soravtansine","Oncology",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Teclistamab","Oncology",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Talquetamab","Oncology",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Relatlimab; nivolumab","Oncology",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Relatlimab; nivolumab","Oncology",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Relatlimab; nivolumab","Oncology",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Relatlimab; nivolumab","Oncology",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Relatlimab; nivolumab","Oncology",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Relatlimab; nivolumab","Oncology",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Dasiglucagon","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Belzutifan","Oncology",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Vosoritide","Other indication",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Deucravacitinib","Other indication",FALSE,TRUE,TRUE,0.322750665204322,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tapinarof","Other indication",FALSE,TRUE,TRUE,0.348631449298571,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Concizumab","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Concizumab","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Faricimab","Other indication",FALSE,TRUE,TRUE,0.457998843449737,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Teplizumab","Other indication",FALSE,TRUE,TRUE,0.481934422723938,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Inclisiran","Other indication",FALSE,TRUE,TRUE,0.58039748904511,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Dostarlimab","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,TRUE,TRUE,0.630378865741897,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Daridorexant","Other indication",FALSE,TRUE,TRUE,0.726359758890427,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Daridorexant","Other indication",FALSE,TRUE,TRUE,0.726359758890427,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Mitapivat","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Trilaciclib","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Futibatinib","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tralokinumab","Other indication",FALSE,TRUE,TRUE,0.724050378449981,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Abrocitinib","Other indication",FALSE,TRUE,TRUE,0.453730626571079,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Abrocitinib","Other indication",FALSE,TRUE,TRUE,0.453730626571079,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Momelotinib","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Vericiguat","Other indication",FALSE,TRUE,TRUE,0.806689170321755,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Pacritinib","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Lonapegsomatropin","Other indication",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Ganaxolone","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Repotrectinib","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Tirzepatide","Other indication",FALSE,TRUE,TRUE,0.815605635144139,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tivozanib","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Infigratinib","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Tepotinib","Oncology",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Asciminib","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Olutasidenib","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Spesolimab","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Lecanemab","Other indication",FALSE,TRUE,TRUE,0.582216982168431,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Donanemab","Other indication",FALSE,TRUE,TRUE,0.582216982168431,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Vutrisiran","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Sotorasib","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Adagrasib","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tofersen","Other indication",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Valoctocogene roxaparvovec","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Olipudase alfa","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Mavacamten","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Mobocertinib","Oncology",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Amivantamab","Oncology",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2021
"progeny","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Voclosporin","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Viloxazine","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Ublituximab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tezepelumab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Terlipressin","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tebentafusp","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Sutimlimab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","SRP-9001","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","SER-109","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","RSVpreF","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Ponesimod","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Pafolacianine","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Oteseconazole","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Olorofim","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Nedosiran","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Maribavir","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Lenacapavir","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","GSK3844766A","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Fosdenopterin","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Fexinidazole","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Evinacumab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Difelikefalin","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Casimersen","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Belumosudil","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Avacopan","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Atogepant","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Anifrolumab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Anacaulase","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Aducanumab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Zuranolone","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Zuranolone","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Tremelimumab","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Umbralisib","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Odevixibat","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Maralixibat","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Finerenone","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Eflapegrastim","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Teclistamab","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Talquetamab","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Dasiglucagon","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Belzutifan","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Vosoritide","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Deucravacitinib","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tapinarof","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Concizumab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Concizumab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Faricimab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Teplizumab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Inclisiran","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Dostarlimab","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,TRUE,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Daridorexant","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Daridorexant","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Mitapivat","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Trilaciclib","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Futibatinib","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tralokinumab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Abrocitinib","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Abrocitinib","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Momelotinib","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Vericiguat","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Pacritinib","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Ganaxolone","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Repotrectinib","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Tirzepatide","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tivozanib","Oncology",FALSE,TRUE,TRUE,0.611001138042729,"Progeny","Functional genomics (cancer)",2021
"progeny","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Infigratinib","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Tepotinib","Oncology",FALSE,TRUE,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Asciminib","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Olutasidenib","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Spesolimab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Lecanemab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Donanemab","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Vutrisiran","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Sotorasib","Oncology",FALSE,TRUE,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Adagrasib","Oncology",FALSE,TRUE,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tofersen","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Valoctocogene roxaparvovec","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Olipudase alfa","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Mavacamten","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Mobocertinib","Oncology",FALSE,TRUE,TRUE,0.593265567332442,"Progeny","Functional genomics (cancer)",2021
"progeny","Amivantamab","Oncology",FALSE,TRUE,TRUE,0.593265567332442,"Progeny","Functional genomics (cancer)",2021
"slapenrich","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Voclosporin","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Viloxazine","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Ublituximab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tezepelumab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Terlipressin","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tebentafusp","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Sutimlimab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","SRP-9001","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","SER-109","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","RSVpreF","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Ponesimod","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Pafolacianine","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Oteseconazole","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Olorofim","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Nedosiran","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Maribavir","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Lenacapavir","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","GSK3844766A","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Gadopiclenol","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Fosdenopterin","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Fexinidazole","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Evinacumab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Difelikefalin","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Casimersen","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Belumosudil","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Avacopan","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Atogepant","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Anifrolumab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Anacaulase","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Aducanumab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Zuranolone","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Zuranolone","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Tremelimumab","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Umbralisib","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Odevixibat","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Maralixibat","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Finerenone","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Eflapegrastim","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Teclistamab","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Talquetamab","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Relatlimab; nivolumab","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Dasiglucagon","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Belzutifan","Oncology",FALSE,NA,TRUE,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Vosoritide","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Deucravacitinib","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tapinarof","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Concizumab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Concizumab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Faricimab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Teplizumab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Inclisiran","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Dostarlimab","Oncology",FALSE,TRUE,TRUE,0.607930797611621,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Daridorexant","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Daridorexant","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Mitapivat","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Trilaciclib","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Futibatinib","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tralokinumab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Abrocitinib","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Abrocitinib","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Momelotinib","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Vericiguat","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Pacritinib","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Ganaxolone","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Repotrectinib","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Tirzepatide","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tivozanib","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Avalglucosidase alfa","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Infigratinib","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Tepotinib","Oncology",FALSE,TRUE,TRUE,0.957622468381807,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Asciminib","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Olutasidenib","Oncology",FALSE,TRUE,TRUE,0.76516056090965,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Spesolimab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Lecanemab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Donanemab","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Vutrisiran","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Sotorasib","Oncology",FALSE,TRUE,TRUE,0.989052667521338,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Adagrasib","Oncology",FALSE,TRUE,TRUE,0.989052667521338,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tofersen","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Valoctocogene roxaparvovec","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Olipudase alfa","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Mavacamten","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Mobocertinib","Oncology",FALSE,TRUE,TRUE,0.977654451498777,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Amivantamab","Oncology",FALSE,TRUE,TRUE,0.977654451498777,"SlapEnrich","Functional genomics (cancer)",2021
"uniprot_literature","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Voclosporin","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Viloxazine","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Ublituximab","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tezepelumab","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Terlipressin","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tebentafusp","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Sutimlimab","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","SRP-9001","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","SER-109","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","RSVpreF","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Ponesimod","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Pafolacianine","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Oteseconazole","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Olorofim","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Nedosiran","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Maribavir","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Lenacapavir","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","GSK3844766A","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Fosdenopterin","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Fexinidazole","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Evinacumab","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Difelikefalin","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Casimersen","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Belumosudil","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Avacopan","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Atogepant","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Anifrolumab","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Anacaulase","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Aducanumab","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Zuranolone","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Zuranolone","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Tremelimumab","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Umbralisib","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Odevixibat","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Maralixibat","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Finerenone","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Eflapegrastim","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Teclistamab","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Talquetamab","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Dasiglucagon","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Belzutifan","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Vosoritide","Other indication",FALSE,NA,TRUE,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Deucravacitinib","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tapinarof","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Concizumab","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Concizumab","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Faricimab","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Teplizumab","Other indication",FALSE,TRUE,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Inclisiran","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Dostarlimab","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Daridorexant","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Daridorexant","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Mitapivat","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Trilaciclib","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Futibatinib","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tralokinumab","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Abrocitinib","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Abrocitinib","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Momelotinib","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Vericiguat","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Pacritinib","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Ganaxolone","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Repotrectinib","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Tirzepatide","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tivozanib","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Avalglucosidase alfa","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Infigratinib","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Tepotinib","Oncology",FALSE,TRUE,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Asciminib","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Olutasidenib","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Spesolimab","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Lecanemab","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Donanemab","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Vutrisiran","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Sotorasib","Oncology",FALSE,TRUE,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Adagrasib","Oncology",FALSE,TRUE,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tofersen","Other indication",FALSE,TRUE,TRUE,0.759913497014526,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Valoctocogene roxaparvovec","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Olipudase alfa","Other indication",FALSE,TRUE,TRUE,0.759913497014526,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Mavacamten","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Mobocertinib","Oncology",FALSE,TRUE,TRUE,0.759913497014526,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Amivantamab","Oncology",FALSE,TRUE,TRUE,0.759913497014526,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_variants","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Voclosporin","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Viloxazine","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Ublituximab","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tezepelumab","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Terlipressin","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tebentafusp","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Sutimlimab","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","SRP-9001","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","SER-109","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","RSVpreF","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Ponesimod","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Piflufolastat F-18","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Pegcetacoplan","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Pafolacianine","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Oteseconazole","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Omidenepag isopropyl","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Olorofim","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Olanzapine; samidorphan","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Nedosiran","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Melphalan flufenamide","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Maribavir","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Loncastuximab tesirine","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Lenacapavir","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Ibrexafungerp","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","GSK3844766A","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Fosdenopterin","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Fexinidazole","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Evinacumab","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Efgartigimod alfa","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Drospirenone; estetrol","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Difelikefalin","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","DaxibotulinumtoxinA","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Casimersen","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Cabotegravir; rilpivirine","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Belumosudil","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Avacopan","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Atogepant","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Asparaginase erwinia chrysanthemi","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Anifrolumab","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Anacaulase","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Aducanumab","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Zuranolone","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Zuranolone","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Tremelimumab","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Umbralisib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Ropeginterferon alfa-2b","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Odevixibat","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Mosunetuzumab","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Maralixibat","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Finerenone","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Eflapegrastim","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tisotumab vedotin","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Mirvetuximab soravtansine","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Teclistamab","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Talquetamab","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Relatlimab; nivolumab","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Dasiglucagon","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Belzutifan","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Vosoritide","Other indication",FALSE,NA,TRUE,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Deucravacitinib","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tapinarof","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Concizumab","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Concizumab","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Faricimab","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Teplizumab","Other indication",FALSE,TRUE,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Inclisiran","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Dostarlimab","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Lutetium Lu-177 vipivotide tetraxetan","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Daridorexant","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Daridorexant","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Mitapivat","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Trilaciclib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Futibatinib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tralokinumab","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Abrocitinib","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Abrocitinib","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Momelotinib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Vericiguat","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Pacritinib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Dexmethylphenidate; serdexmethylphenidate","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Lonapegsomatropin","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Ganaxolone","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Repotrectinib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Tirzepatide","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tivozanib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Avalglucosidase alfa","Other indication",FALSE,TRUE,TRUE,0.991954133440882,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Infigratinib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Tepotinib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Asciminib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Olutasidenib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Spesolimab","Other indication",FALSE,TRUE,TRUE,0.865457038266544,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Lecanemab","Other indication",FALSE,TRUE,TRUE,0.951397496038773,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Donanemab","Other indication",FALSE,TRUE,TRUE,0.951397496038773,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Vutrisiran","Other indication",FALSE,TRUE,TRUE,0.985702485030815,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Sotorasib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Adagrasib","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tofersen","Other indication",FALSE,TRUE,TRUE,0.993957066521561,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Valoctocogene roxaparvovec","Other indication",FALSE,TRUE,TRUE,0.996581126096353,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Olipudase alfa","Other indication",FALSE,TRUE,TRUE,0.991954133440882,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Mavacamten","Other indication",FALSE,TRUE,TRUE,0.995966686845765,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Mobocertinib","Oncology",FALSE,TRUE,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Amivantamab","Oncology",FALSE,TRUE,NA,0,"Uniprot (variants)","Rare mendelian",2021
